baber/WOPTO huggingface dataset:
Patent NZ-302523-A (NZ)
Title: Detecting and bypassing tandem vocoding
Inventor: WEAVER LINDSAY A
IPC: G10L25/78
Filed: 1996-01-25
Abstract: When one vocoding system is coupled to another vocoding system, a tandem arrangement results. The tandem configuration results in voice quality degradation as speech is encoded and decoded, then encoded and decoded again. One reason for the degradation is that postfiltering performed at the output of the speech decoding process introduces distortions in the spectral content of the reconstructed speech as compared to the original speech. The present invention prevents the degradation due to the use of postfilters by modifying the postfiltering within the vocoders where a tandem configuration exists. A detection code is embedded within the data signal to indicate the existence of a tandem configuration. If the detection code is received at a vocoder, modified vocoding is established within the vocoders to prevent the degradation due to the postfiltering.
Patent NZ-318732-A (NZ)
Title: Tamper evident syringe design
Inventor: HAJJAR ELIAS
IPC: A61M5/31
Filed: 1996-10-04
Abstract: plastic prefilled syringe (10) including a syringe body (11) and a plunger assembly (12), the syringe body (11) having opposed first (13) and second (14) ends and an inner wall (16) defining a cylindrical chamber (15) which contains an injectable solution (100), the first end (13) of the syringe body (11) being sealed by a closure and the second end (14) incorporating an opening (18), the plunger assembly (12) including a plunger shaft (22) extending through said opening (18) and a stopper (24) secured at an end of said shaft (22) within said chamber, the plunger assembly (12) being movable within the chamber with the stopper (24) being operable to seal the opening (18) wherein the plunger assembly (12) includes barrier means (26 and 29) on said shaft (22) the barrier means (26 and 29) being adapted, in conjunction with a part of the syringe body (16 and 19), to inhibit access to the injectable solution (100) through the opening (18).
Patent NZ-320522-A (NZ)
Title: Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds
Inventor: JAKOCZI IVAN
IPC: A61K31/506
Filed: 1996-10-25
Abstract: PCT No. PCT/HU96/00061 Sec. 371 Date Jun. 23, 1998 Sec. 102(e) Date Jun. 23, 1998 PCT Filed Oct. 25, 1996 PCT Pub. No. WO97/16429 PCT Pub. Date May 9, 1997The invention refers to novel piperazinylalkylthiopyrimidine derivatives of formula (I) being suitable for the treatment of diseases due to pathological alterations of the central nervous system, pharmaceutical compositions containing the above derivatives, and a process for the preparation of the novel compounds.
Patent NZ-333821-A (NZ)
Title: process for preparing a composition containing vitamin B12 and biomass from the micro organisms
Inventor: BIJL HENDRIK LOUIS
IPC: A23L33/15
Filed: 1997-08-12
Abstract: The process for the preparation of a composition comprising natural vitamin B12 comprises: a) obtaining microbial cells containing natural vitamin B12, b) causing opening of the microbial cells such that at least part of the soluble content of the cells comprising the vitamin B12 is released in a liquid in which the cells are contained, c) separating the opened cells and the liquid comprising the vitamin B12, and d) preparing a composition of the vitamin B12 and at least a part of the opened cells. The composition has a vitamin B12 concentration on dry matter in excess of 0.1 % (w/w) ad the term natural vitamin B12 includes all of the cobalt corrinoids of the colbalmin group except cyancobalamin.
Patent NZ-335062-A (NZ)
Title: Method and apparatus for automated opening of options exchange
Inventor: RICKARD JOHN T
IPC: G06Q40/00
Filed: 1997-09-08
Abstract: A computer-based system for determining a set of opening prices for a number of series of options traded on an options exchange and for allocating public order imbalances at the opening of trading, is disclosed.  Market makers input a current position, a desired target position and market maker orders (104) for options series from market maker terminals.  An order entry system receives public orders (102) for options series.  A controller (2) determines a set of implied volatilities (prices) for each options series that will maximize a weighted volume of trades across all options series at the opening.  Means for executing all orders that can occur at the set of prices is executed.  If there is a residual imbalance of non-executed public orders, the residual imbalance of non-executed public orders is assigned to individual ones of the plurality of market makers so as to minimize a cumulative measure of deviation between the desired target position and the current position of each market maker.  The system is applicable to an options exchange, this term including any facility operating an over-the-counter market in options.
Patent NZ-336939-A (NZ)
Title: Multimedia communication via telephony (circuit switched) and packet switched (internet) networks
Inventor: EASTEP GUIDO M
IPC: H04L29/06
Filed: 1998-02-03
Abstract: A system and method for routing telephone calls, data and other multimedia information through a hybrid network includes transfer of information across the Internet. Profile information is utilized by the system throughout the media experience for routing, billing, monitoring, reporting and other media control functions. Prioritized routing may be accomplished. Callback sessions may be performed and a display presented to a caller via a web page that includes status information pertaining to the callback session. Calls and callbacks can also be routed over the hybrid network.  To implement callback, a user is prompted for destination information to initiate a callback session on the hybrid network of a switched network, a switched packet network, and a directory of Internet protocol addresses for the packet switched network.  The destination information includes an identifier to identify a destination of the callback session.  A call router connecting the switched network and the packet switched network routes a media communication by accessing the directory of Internet protocol addresses and identifying an Internet protocol address associated with the destination of the callback session.
Patent NZ-337095-A (NZ)
Title: High voltage power transformer/inductor with second semi-conductor layer earthed directly at ends and indirectly between ends
Inventor: FROMM UDO
IPC: H01F27/34
Filed: 1998-02-02
Abstract: Disclosed is a power transformer/inductor comprising at least one winding. The windings are designed by means of a high voltage cable (10), comprising an electric conductor, and around the conductor there is arranged a first semi-conducting layer (14), around the first semi-conducting layer (14) there is arranged an insulating layer (16) and around the insulating layer (16) there is arranged a second semi-conducting layer (18). The second semi-conducting layer (18) is directly earthed at both ends of each winding (221, 222) and furthermore at least at two points per turn of every winding (221, 222), whereby one or several points are indirectly earthed.
Patent NZ-337503-A (NZ)
Title: 2-alkylidene-19-nor-vitamin D compounds
Inventor: DELUCA HECTOR F
IPC: C07F7/18
Filed: 1998-02-11
Abstract: 2-alkylidene-19-nor-vitamin D derivatives of formula (I), where Y1 and Y2, which may be the same or different, are each selected from the group consisting of hydrogen and a hydroxy-protecting group, R6 and R8, which may be the same or different, are each selected from hydrogen, alkyl, hydroxyalkyl and fluoroalkyl, or when taken together represent the group -(CH2)x- where x is an integer from 2 to 5, and where the group R represents any of the typical side chains known for vitamin D type compounds. These 2-substituted compounds are characterized by low intestinal calcium transport activity and high bone calcium mobilization activity resulting in novel therapeutic agents for the treatment of diseases where bone formation is desired, particularly low bone turnover osteoporosis. These compounds also exhibit pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as anti-cancer agents and for the treatment of diseases such as psoriasis.
Patent NZ-504061-A (NZ)
Title: Assay device for determination of analyte in a solution has sample uptake islands on an elongate support housed within a pipette
Inventor: PIERSON MARK W
IPC: B01J19/00
Filed: 1998-10-27
Abstract: Method and assay devices for the detection of the presence or amount of biological material, analyte(s), or microorganism(s) in a sample. The method includes the steps of liquefying the sample (if necessary) and distributing the liquefied sample over the surface of the assay device. The device may comprise an incubation plate, a dip stick device, or other devices. The devices have at least one reagent provided within the devices. Some devices have a generally flat horizontal surface which is divided into a plurality of recessed wells. Others have one or more surfaces with reagent island(s) immobilized thereon. Each well or reagent island is adapted to hold an aliquot of liquid. The wells or reagent islands are sized and shaped, and formed of a suitable material, to hold the aliquot within the well or reagent island by surface tension. Any excess liquid from the liquefied sample is drained from the surface of the device. The method then involves incubating the assay device until the presence or amount of the biological material, analyte, or microorganism is determined.
Patent NZ-505148-A (NZ)
Title: Use of endokine alpha antagonists to diagnose and treat TNF-related disorders
IPC: C12P21/08
Filed: 1996-08-16
Abstract: Nucleic acid molecules comprising a polynucleotide encoding a cytokine that is similar to tissue necrosis factor-á (TNF-á) are disclosed.  This cytokine is named endokine alpha and is believed to have similar biological effects and activities to TNF.  This cytokine also includes endokine alpha polypeptides having at least a portion of the amino acid sequence in SEQ ID NO:2 or an amino acid sequence encoded by the cDNA clone deposited in a bacterial host as ATCC Deposit Number 97640 on June 27, 1996.  The nucleotide sequence, which was determined by sequencing the endokine alpha cDNA clone, contains an open reading frame encoding a polypeptide of about 169 amino acid residues including an N-terminal methionine, an intracellular domain of about 17 amino acid residues, a transmembrane domain of about 26 amino acids, an extracellular domain of about 126 amino acids, and a deduced molecular weight for the complete protein of about 19 kDa.  The 126 amino acid sequence of the expected mature endokine alpha protein of SEQ ID NO:2 (residues 44 to 169). Antibodies or antibody fragments that bind specifically to the polypeptide disclosed have a use in decreasing the level of endokine alpha activity and may be useful diagnostically or therapeutically as antagonists in the treatment of endokine alpha- and/or TNP related disorders.
Patent NZ-506770-A (NZ)
Title: Fixture placement device
Inventor: FOWLER JOHN EDWARD FOX
IPC: F16L5/00
Filed: 2000-09-06
Abstract: A bracket 100 to assist in the installation of an outlet for a service such as electricity, during construction or renovation of a building includes a bracket mounting means which forms part of a first elongated member 101.  First elongated member 101 is continuous with a second perpendicular elongate member 102 having position marking means 104 capable of piercing a subsequently placed surface board 302.  Second elongate member 102 is continuous with a first end of a third elongated member 103 serving as a strut for the bracket.  Third elongate member 103 includes at least one service carrier holding means 105 or 105A.  Third elongate member 103 has a second end contiguous with first elongate member 101 at a joint capable of providing an effective strength to the bracket until second elongate member 102 is separated so that the service carrier can be retrieved from behind the surface board.
Patent NZ-507239-A (NZ)
Title: Game piece in form of quoit with multiple distinct zones used for scoring
Inventor: DELANY FRANCIS LAURENCE
IPC: A63F9/02
Filed: 2000-09-28
Abstract: Quoit 1 has body 1 with scoring zones passing therethrough. Quoit 1 is thrown at one or more upstanding pins (not shown). At least one pin can pass through one of these zones but cannot simultaneously pass through any other of the scoring zones.
Patent NZ-508908-A (NZ)
Title: Process for the preparation of hydroxymethylthiobutyric acid
Inventor: GARRAIT MICHEL
IPC: C07C319/20
Filed: 1999-07-07
Abstract: A process for hydrolyzing 2-hydroxy-4-methylthiobutyronitrile with sulfuric acid, characterised in that a molar quantity of sulfuric acid of between 0.6 and 0.88 relative to the 2-hydroxy-4-methylthiobutyronitrile is used.  In a first step, the hydration of 2-hydroxy-4-methylthiobutyronitrile to 2-hydroxy-4-methylthiobutyramide is carried out with concentrated sulfuric acid in the presence of a water to 2-hydroxy-4-methylthiobutyronitrile molar ratio of between 1 and 3 at a temperature of less than or equal to 60oC.  In a second step, the hydrolysis of 2-hydroxy-4-methylbutyramide to 2-hydroxy-4-methylthiobutyric acid is carried out in the presence of an additional quantity of water.
Patent NZ-516236-A (NZ)
Title: Altering life span of a recipient cell by transferring cell cytoplasm from a donor cell for use in gene therapy and cloning
Inventor: CHAPMAN KAREN B
IPC: A61K35/12
Filed: 2000-06-30
Abstract: An in vitro or ex vivo method for reprogramming and/or altering the life-span of a desired cell (recipient cell) comprising solely introducing into the cell cytoplasm from another less differentiated or undifferentiated cell (donor cell) wherein the recipient cell is not enucleated. The recipient cell may be genetically modified prior, concurrent and/or subsequent to the introduction of the cytoplasm and the cell can then be used in the manufacture of a medicament from treating a disease treatable by genetic therapy. Methods of cloning non-human mammals via nuclear transfer using reprogrammed or lifespan altered cells as the donor mammalian cells and methods for producing a culture comprising embryonic stem cells are described.
Patent NZ-518270-A (NZ)
Title: A rollable mesh apparatus
Inventor: GREY ROSS VICTOR
IPC: B21F27/12
Filed: 2000-10-19
Abstract: The present invention relates generally to an apparatus (10) for fabricating a reinforcing element (12). The reinforcing element (12) includes a plurality of elongate load bearing reinforcing members such as (14A and 14B) having adjacent members connected by generally transversely oriented non-load bearing links of an adhesive tape (16A and 16B). The apparatus (10) comprises means for receiving (18) each of the reinforcing members or bars such as (14B), and means for sequentially applying the adhesive tape (16A and 16B) to the reinforcing bars such as (14A and 14B).
Patent NZ-524296-A (NZ)
Title: Method for the assembly of a mobile radio network base station and connection of the base station to the network
Inventor: RITTER RUDOLF
IPC: H04Q7/30
Filed: 2000-07-26
Abstract: This  method  is for setting up a base  station  of  a mobile radio network and for connecting the base station  to the   mobile  radio  network,  which  mobile  radio  network comprises at least one mobile-service switching center, with a transmission/reception area assigned to the mobile-service switching  center, and one or more base station  controllers each  with  one  or  more base stations,  the  mobile  radio network  being  connected  via the mobile-service  switching center  to the public switched telephone network,  the  base station  controllers being connected to  the  mobile-service switching  center  and  comprising  monitoring  and  control functions  for the base stations, one or more  of  the  base stations  in each case being connected to a common  assigned base   station  controller,  and  the  base  stations   each comprising  means  for exchange of radio  frequency  signals with  mobile radio devices, wherein at least one of the base stations  is  installed in an existing facility  on  exposed public  ground, which facility is supplied by a power supply system, the at least one of the base stations is coupled  to the  power supply system with a first transceiver module,  a second  transceiver module is likewise coupled to the  power supply  system at another location, whereby the transmission of  electrical signals corresponding to the radio  frequency signals  is  made possible bidirectionally  over  the  power supply  system between the transceiver modules by  means  of the  transceiver modules, and the second transceiver  module is  connected to the base station controller assigned to the at   least   one  last-mentioned  base  station,   so   that communication to one another between the at least  one  base station  and the base station controller assigned to  it  is made possible.
Patent NZ-527120-A (NZ)
Title: A kite
Inventor: BARNES PAUL DANIEL LOUIS
IPC: B64C31/06
Filed: 2003-07-21
Abstract: Disclosed is a kite (figure 1) having or including one or more membrane type panel(s) alone or collectively defining at least substantially all of the leading edge, trailing edge and the lateral expanse of the kite, at least a keel from at or adjacent each lateral extremity, such a keel form being (directly or indirectly) each attachable to or attached to a control line or a bridle connecting or connectable to a control line, and a fore and aft extending inflated or inflatable beam at or adjacent each lateral extremity and/or each keel form at or adjacent the lateral extremity, wherein, at least two of said beams are not parallel with each other or one another resulting in a taper from the leading edge to the trailing edge.
Patent NZ-528885-A (NZ)
Title: Method and device for detecting a leak in a heat exchanger, especially a plate-type heat exchanger
Inventor: RABELLE GERARD
IPC: G01M3/32
Filed: 2002-04-10
Abstract: A method for detecting a leak between two circuits of a plate-type exchanger, each of the two circuits of the plate-type heat exchanger is filled with a fluid at a different pressure, characterised in that the change in pressure in the two circuits is observed. The pressure is observed in the two circuits for a convergence of pressures, observation involving periodically calculating the difference between the two pressures is undertaken, when a convergence of the two circuit pressures is automatically monitored below a certain threshold a leak is signalled.
Patent NZ-530954-A (NZ)
Title: Expression profile of EZH2 gene in prostate cancer
Inventor: RUBIN MARK A
IPC: C12Q1/68
Filed: 2002-08-02
Abstract: Disclosed are methods for detecting the presence or absence of EZH2 expression in tumour tissue. EZH2 is a gene that has been identified as a marker for, but not limited to, prostate cancer. In particular, gene expression profiles associated with prostate cancers are provided. Using the disclosed methods the expression of EZH2 can be measured and can find use in the characterization of prostate cancer. In addition, the genes provide targets for cancer drug screens and therapeutic applications.
Patent NZ-531145-A (NZ)
Title: Lubrication of a pitch angle adjusting device of a rotor blade of a windmill
Inventor: WOBBENS ALOYS
IPC: F03D80/70
Filed: 2002-08-22
Abstract: Apparatus for rotating a shaft of a rotor blade 4 of a wind power installation relative to a hub 8 of the installation is disclosed. A bearing arrangement 18 is located between the rotor blade and hub and there is a gear drive for actuating rotary movement to adjust the pitch angle of the rotor blade. A gear 16 of the drive and the bearing arrangement are both arranged in the volume region of a lubricant chamber 20 and a lubricant feed is effected through the bearing.
Patent NZ-534701-A (NZ)
Title: Method of attaching an end seal to manufactured seed
Inventor: HIRAHARA EDWIN
IPC: C30B28/10
Filed: 2004-08-16
Abstract: A method of attaching an end seal to a manufactured seed is provided. The method includes providing a manufactured seed having an open end and inflating a sealing material to form an enclosure having an interior surface. The method also includes placing the enclosure into contact with the open end of the manufactured seed and attaching the enclosure to the manufactured seed to seal the open end of the manufactured seed.
Patent NZ-537015-A (NZ)
Title: Anti-tumour polycyclic carboxamides with cytotoxicity
Inventor: BAGULEY BRUCE CHARLES
IPC: A61P35/00
Filed: 2003-05-12
Abstract: The disclosure relates to polycyclic carboxamide compounds of the formula (I) with cytotoxicity, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prophylaxis of cellular proliferative disorders such as cancer.
Patent NZ-539602-A (NZ)
Title: Use of serotonin receptior antagonists for the treatment of sleep apnea
Inventor: RADULOVACKI MIODRAG
IPC: A61K31/167
Filed: 2003-10-29
Abstract: Disclosed is a use of at least one serotonin receptor antagonist in free base or quaternized form in the manufacture of a medicament for preventing or ameliorating a sleep-related breathing disorder in a patient in need thereof, wherein the serotonin receptor antagonist is selected from the group of compounds described in the specification.
Patent NZ-541117-A (NZ)
Title: Alpha-aminoamide derivatives useful as antimigraine agents
Inventor: SALVATI PATRICIA
IPC: A61K31/165
Filed: 2003-11-18
Abstract: Disclosed is the use of alpha-aminoamide derivatives of formula (I) useful as antimigraine agents, particularly for the treatment of head pain conditions involving a cerebral vasodilatation mechanism such as migraine, cluster headache or other severe headache. The antimigraine agents are able to reduce or even stop the pain deriving from such conditions without, virtually, any side effects.
Patent NZ-544807-A (NZ)
Title: Dispensing closure
Inventor: IRWIN JOHN SEYMOUR
Filed: 2006-01-19
Abstract: A dispensing closure for dispensing contents of a container comprises a first closure member which includes a primary dispensing aperture and a second closure member 14 associated with the first closure member and rotatable relative thereto. The second closure member 14 includes one or more secondary dispensing apertures 18, the or each of which are adapted to dispense the contents of the container when the first and second closure members are moved relative to one another so that the primary and secondary dispensing apertures are aligned. The or each secondary dispensing aperture 18 is generally broader at one end than the other end.
Patent NZ-546987-A (NZ)
Title: Methods and compositions for the treatment of hypoglycemia, glycogen storage disease and liver disease using heat moisture treated starch or annealing treated starch
Inventor: QI XIN
IPC: A23L1/0522
Filed: 2004-11-08
Abstract: Disclosed is the use of a starch in the preparation of a therapeutic food composition or therapeutic foodstuff for the treatment of hypoglycemia or hypoglycemic episodes in an individual, wherein said starch is a heat moisture treated starch or annealing treated starch.
Patent NZ-551438-A (NZ)
Title: Pyrimidine urea derivatives useful for the treatment of protein kinase dependent diseases
Inventor: DING QIANG
IPC: A61K31/505
Filed: 2005-06-23
Abstract: Disclosed herein are pyrimidine urea derivatives of formula (I) wherein the substituents are as defined within the specification, pharmaceutical compositions containing the same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of a disease which responds to an inhibition of protein kinase activity, and a method for the treatment of such a disease such as cancer and multiple myeloma.